Expert Insights on Diabetes

Diabetes is a disease characterized by the body's inability to sufficiently produce insulin to properly metabolize carbohydrates. The three main forms the condition are Type 1, Type 2, and gestational diabetes. Type 1 diabetes is a chronic disease characterized by destruction of beta-cells of the pancreas. Type 2 diabetes develops when the body becomes resistant to the effects of insulin. Gestational diabetes is usually a temporary disorder occurring during pregnancy when insulin resistance develops due to hormonal changes and weight gain.

Gerson Lehrman Group Council Members are available to discuss Diabetes via phone consultations, live meetings, surveys, and other custom GLG products and services.

Find, engage, and manageSM experts today through the GLG platform

Featured Council Members

GLG Council Members are leading experts including academics, scientists, and industry specialists

Michael Dempsey, Medical Director, SUBURBAN HOSPITAL, INC

Michael Dempsey What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Medical DirectorSUBURBAN HOSPITAL, INC

Michael Dempsey, Medical Director, SUBURBAN HOSPITAL, INC

Michael Dempsey What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Medical DirectorSUBURBAN HOSPITAL, INC

Kelly Close, President, Close Concerns

Kelly Close What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

PresidentClose Concerns

Marina Raikhel, Director, TORRANCE MEMORIAL MEDICAL CENTER

Marina Raikhel What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

DirectorTORRANCE MEMORIAL MEDICAL CENTER

Richard Levy, Assistant Professor of Medicine and Pediatrics, RUSH UNIVERSITY MEDICAL CENTER

Richard Levy What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Assistant Professor of Medicine and PediatricsRUSH UNIVERSITY MEDICAL CENTER

Browse all 364 Leading Experts

Study Groups

Study groups are populations of experts knowledgeable on specific sub-topics within a broader industry

Study Group Name No. Members
Byetta Prescribers for Diabetes 294
Byetta Prescribers for Diabetes (US) 263
Byetta Prescribers for Diabetes: Endocrinologists 159
Byetta Prescribers for Diabetes 294
Byetta Prescribers for Diabetes (US) 263

Browse all 981 Study Groups

Recent News Analyses

News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations

Is the End of the Beginning of Diabetes Coming?

October 11, 2009

GLG Expert Contributor

Diabetes Care Article Shows Sustained Benefits of CGM

September 18, 2009

Kelly Close, President, Close Concerns

Amylin Partners with Biocon to Develop Novel Diabetes Therapeutic

September 15, 2009

Kelly Close, President, Close Concerns

Metagliptin too?

September 21, 2009

GLG Expert Contributor

Clinical efficacy for Linagliptin - results from phase III trials

September 29, 2009

GLG Expert Contributor

Browse all 8743 GLG News Analyses

Contact Gerson Lehrman Group to engage a Diabetes expert